Subtopic Deep Dive

Stability Indicating Assays
Research Guide

What is Stability Indicating Assays?

Stability Indicating Assays (SIAs) are analytical methods designed to detect and quantify degradation products of active pharmaceutical ingredients under stress conditions while distinguishing them from the parent drug.

SIAs ensure drug stability monitoring for shelf-life determination and regulatory compliance. Common techniques include HPLC, LC-MS, and voltammetry. Over 10 key papers from 1997-2022 document SIA development, with Kowalska et al. (2022) leading at 2092 citations.

15
Curated Papers
3
Key Challenges

Why It Matters

SIAs underpin pharmaceutical quality control by verifying drug efficacy during storage and transport, as shown in Mohammadi et al. (2006) assay for atorvastatin and amlodipine tablets (169 citations). They support FDA/ICH guidelines for forced degradation studies, enabling formulation optimization in SMEDDS systems (Patel and Vavia, 2007; 270 citations). Greener SIA methods reduce environmental impact while maintaining sensitivity (Yabré et al., 2018; 246 citations).

Key Research Challenges

Degradation Product Separation

Distinguishing closely eluting degradation products from APIs challenges HPLC method development. Stress testing reveals impurities not resolved by standard conditions (Kowalska et al., 2022). Column stability at extreme pH adds complexity (Kirkland et al., 1997).

Method Validation Rigor

ICH Q2(R1) requires specificity, linearity, and robustness validation under variable conditions. Multi-analyte assays like atorvastatin-amlodipine demand simultaneous optimization (Mohammadi et al., 2006). High citation works emphasize reproducible impurity profiling (2092 citations for Kowalska et al., 2022).

Green Analytical Compliance

Traditional RP-HPLC solvents harm environment; alternatives must preserve sensitivity. Greening efforts target pharma analysis without sensitivity loss (Yabré et al., 2018). LC-MS integration balances eco-friendliness with detection limits (Beccaria and Cabooter, 2020).

Essential Papers

1.

Management of validation of HPLC method for determination of acetylsalicylic acid impurities in a new pharmaceutical product

Małgorzata Kowalska, Magdalena Woźniak, Michał Kijek et al. · 2022 · Scientific Reports · 2.1K citations

2.

FIP/AAPS guidelines to dissolution/in vitro release testing of novel/special dosage forms

Martin Siewert, Jennifer Dressman, Cynthia K. Brown et al. · 2003 · AAPS PharmSciTech · 365 citations

3.

Preparation and in vivo evaluation of SMEDDS (self-microemulsifying drug delivery system) containing fenofibrate

Ashok R. Patel, Pradeep R. Vavia · 2007 · The AAPS Journal · 270 citations

4.

A sensitive voltammetric sensor for determination of synthetic corticosteroid triamcinolone, abused for doping

Rajendra N. Goyal, Vinod K. Gupta, Sanghamitra Chatterjee · 2009 · Biosensors and Bioelectronics · 260 citations

5.

Greening Reversed-Phase Liquid Chromatography Methods Using Alternative Solvents for Pharmaceutical Analysis

Moussa Yabré, Ludivine Ferey, Issa T. Somé et al. · 2018 · Molecules · 246 citations

The greening of analytical methods has gained increasing interest in the field of pharmaceutical analysis to reduce environmental impacts and improve the health safety of analysts. Reversed-phase h...

6.

Current developments in LC-MS for pharmaceutical analysis

Marco Beccaria, Deirdre Cabooter · 2020 · The Analyst · 221 citations

Liquid chromatography (LC) based techniques in combination with mass spectrometry (MS) detection have had a large impact on the development of new pharmaceuticals in the past decades.

7.

Development, characterization and stabilization of amorphous form of a low Tg drug

Varsha Pokharkar, Leenata Mandpe, Mahesh N. Padamwar et al. · 2006 · Powder Technology · 176 citations

Reading Guide

Foundational Papers

Start with Mohammadi et al. (2006) for practical HPLC SIA in tablets and Siewert et al. (2003; 365 citations) for regulatory guidelines on novel forms, establishing validation baselines.

Recent Advances

Study Kowalska et al. (2022; 2092 citations) for high-impact impurity management and Beccaria and Cabooter (2020; 221 citations) for LC-MS advances in pharma analysis.

Core Methods

Core techniques: Forced degradation HPLC (acid/base/peroxide/UV), peak purity by diode array (Mohammadi et al., 2006), green RP-HPLC solvents (Yabré et al., 2018), and voltammetric sensors (Goyal et al., 2009).

How PapersFlow Helps You Research Stability Indicating Assays

Discover & Search

Research Agent uses searchPapers('stability indicating assay HPLC pharmaceuticals') to retrieve Kowalska et al. (2022; 2092 citations), then citationGraph reveals citing works on impurity validation and findSimilarPapers uncovers Yabré et al. (2018) for green methods.

Analyze & Verify

Analysis Agent applies readPaperContent on Mohammadi et al. (2006) to extract HPLC parameters, verifyResponse with CoVe checks degradation peak resolution claims against ICH standards, and runPythonAnalysis simulates chromatograms using pandas for peak purity stats with GRADE scoring for evidence strength.

Synthesize & Write

Synthesis Agent detects gaps in multi-drug SIA coverage from Patel et al. (2007) SMEDDS papers, while Writing Agent uses latexEditText for method sections, latexSyncCitations integrates 10+ refs, and latexCompile generates validated assay protocols with exportMermaid for degradation pathway diagrams.

Use Cases

"Python analysis of HPLC peak purity from stability assay data in Kowalska 2022"

Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas peak deconvolution, matplotlib impurity profiles) → statistical purity report with p-values.

"LaTeX report on validated SIA for atorvastatin-amlodipine tablets"

Analysis Agent → readPaperContent (Mohammadi 2006) → Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations + latexCompile → camera-ready methods paper with figures.

"Find open-source code for voltammetric SIA sensors like Goyal 2009"

Research Agent → paperExtractUrls (Goyal et al. 2009) → Code Discovery → paperFindGithubRepo → githubRepoInspect → verified sensor calibration scripts for triamcinolone detection.

Automated Workflows

Deep Research workflow scans 50+ SIA papers via searchPapers → citationGraph, producing structured reviews of HPLC vs LC-MS evolution with GRADE tables. DeepScan applies 7-step verification to Yabré et al. (2018) green methods, checkpointing solvent impact stats. Theorizer generates hypotheses on column stability from Kirkland et al. (1997) data chains.

Frequently Asked Questions

What defines a Stability Indicating Assay?

SIAs quantify API degradation products under ICH-recommended stress (acid/base/heat/light/oxidation) while separating them from the parent drug via HPLC/LC-MS.

What are common methods in SIAs?

RP-HPLC dominates (Kowalsa et al., 2022; Mohammadi et al., 2006), with LC-MS for trace impurities (Beccaria and Cabooter, 2020) and voltammetry for doping agents (Goyal et al., 2009).

What are key papers on SIAs?

Foundational: Mohammadi et al. (2006; 169 citations) for dual-drug assay; Siewert et al. (2003; 365 citations) for release testing. Recent: Kowalska et al. (2022; 2092 citations) on acetylsalicylic acid impurities.

What are open problems in SIAs?

Ultra-fast separation of co-eluting degradants, pH-stable columns beyond 11 (Kirkland et al., 1997), and fully green solvents without sensitivity loss (Yabré et al., 2018).

Research Analytical Methods in Pharmaceuticals with AI

PapersFlow provides specialized AI tools for Chemistry researchers. Here are the most relevant for this topic:

See how researchers in Chemistry use PapersFlow

Field-specific workflows, example queries, and use cases.

Chemistry Guide

Start Researching Stability Indicating Assays with AI

Search 474M+ papers, run AI-powered literature reviews, and write with integrated citations — all in one workspace.

See how PapersFlow works for Chemistry researchers